Tuesday, 6 May 2014

Another day, another multibillion dollar pharma deal - part 2

Is Hikma Pharmaceuticals the next takeover target in the pharmaceutical sector?

The boys over The Motley Fool certainly seem to think so.

Here is a link to a piece they published this morning outlining why Hikma might be of interest to Mylan, which recently tried to buy Sweden's Meda:


No comments:

Post a Comment